Campbell & CO Investment Adviser LLC

Position in GSK — GSK plc

CIK 1353570 BALTIMORE, MD

Position in GSK

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$4,402,703

+$4,152,803 QoQ

Shares Held

83,989

+1754.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#170

of 1,033 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. GSK ranks #4 (15.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co	3,682	$4,416,301
4	GSK	GSK plc This page	83,989	$4,402,703
5	SNY	Sanofi	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc.	17,781	$2,246,451
7	PFE	Pfizer Inc	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,402,703	83,989	+1754.9%	Shares	Sole	2026-08-03
2026-03-31	$249,900	4,528	-91.8%	Shares	Sole	2026-05-15
2025-12-31	$2,696,415	54,984	+120.6%	Shares	Sole	2026-02-12
2025-09-30	$1,075,935	24,929	-3.5%	Shares	Sole	2025-10-28
2025-06-30	$991,680	25,825	+141.6%	Shares	Sole	2025-08-07
2025-03-31	$414,130	10,690	-91.5%	Shares	Sole	2025-05-14
2024-09-30	$5,119,647	125,236	+45.9%	Shares	Sole	2024-11-12
2024-06-30	$3,304,917	85,842	+548.8%	Shares	Sole	2024-08-13
2023-12-31	$490,340	13,231	-47.6%	Shares	Sole	2024-02-13
2023-06-30	$900,694	25,272	-15.3%	Shares	Sole	2023-08-11
2023-03-31	$1,061,707	29,840	-84.6%	Shares	Sole	2023-05-11
2022-09-30	$5,695,234	193,518	+1769.4%	Shares	Sole	2022-11-14
2020-09-30	$382,168	10,352	—	Shares	Sole	2020-10-15
No filing history on record for this holder in this stock.